Background: This study examined the impact of mitral valve repair (MVRe) on survival of patients with moderate or severe (≥2+) MR and ischemic cardiomyopathy randomized to coronary artery bypas
Additional file 1: Supplemental Figure 1. Overall survival with receiving treatment at academic centers (red) or non-academic center (blue) for (A) patients who did not receive surgery or chemotherapy
